Fungal infections of the skin: Infection process and antimycotic therapy

Current Drug Targets

Volumn 6, Issue 8, 2005, Pages 849-862

  Borgers, M ^a,d   Degreef, H ^b   Cauwenbergh, G ^c  

^a Barrier Therapeutics   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Barrier Therapeutics   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antifungals; Dermatomycoses; Dermatophytes; Prevention; Pulse therapy; Resistance; Skin kinetics; Yeasts

Indexed keywords

ALLYLAMINE DERIVATIVE; AMOROLFINE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZOLINE; BUTENAFINE; CASPOFUNGIN; CICLOPIROX; CORTICOSTEROID; DESONIDE; ECHINOCANDIN; ERGOSTEROL; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KERATIN; KETOCONAZOLE; MICONAZOLE; MORPHOLINE DERIVATIVE; NAFTIFINE; NYSTATIN; POLYENE; PYRROLE DERIVATIVE; SORDARIN DERIVATIVE; TERBINAFINE; TOLCICLATE; TOLNAFTATE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ATOPIC DERMATITIS; CARDIOTOXICITY; CHILL; DERMATOMYCOSIS; DERMATOPHYTE; DIAPER DERMATITIS; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; EPIDERMOPHYTON; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIPOGENESIS; LIVER TOXICITY; MICROSPORUM; NAIL INFECTION; NAUSEA AND VOMITING; NEPHROTOXICITY; NONHUMAN; ONYCHOMYCOSIS; PATHOPHYSIOLOGY; REVIEW; SEBORRHEIC DERMATITIS; SHORT COURSE THERAPY; SIDE EFFECT; TINEA BARBAE; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA FACIEI; TINEA MANUUM; TINEA PEDIS; TINEA VERSICOLOR; TRICHOPHYTON;

ALLYLAMINE; ANTIFUNGAL AGENTS; AZOLES; DERMATOMYCOSES; ERGOSTEROL; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MORPHOLINES;

EID: 27944441257     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945005774912726     Document Type: Review

References (106)

1. Van Cutsem, J. (1989) Curr. Top. Med. Mycol, 3, 1-35.
2. Koga, M.; Sei, Y.; Higuchi, D. and Takiuchi I. (1986) Jpn. J. Med. Mycol, 27, 107-112.
3. Richardson, M.D. and Adjabre, S.H.M. (1993) Curr. Top. Med. Mycol., 5, 49-77.
4. Hartman, P.G. and Polak, A. (1993) in Cutaneous Antifungal Agents, (Rippon, J., Fromtling, R.A., Eds.), Marcel Dekker, Inc., New York, pp. 13-26.
5. Medoff, G. and Kobayashi, G.A. (1980) in Antifungal Chemotherapy, (Speller, D.E.C., Ed.), Wiley & Sons, London, pp. 3-33.
6. Borgers, M. (1980) Rev. Infect. Dis., 2(4), 520-534.
7. Borgers, M. (1988) Curr. Top. Med. Mycol., 2, 1-39.
8. Sloboda, R.D.; Van Blaricom, G.; Creasey, W.A.; Rosenbaum, J.L. and Malawista, S.E. (1982) Biochem. Biophys. Res. Commun., 105(3), 882-888.
9. Hossain, M.A. and Ghannoum, M.A. (2001) Expert. Opin. Investig. Drugs, 10(8), 1501-1511.
10. Malawista, S.E. (1975) Ann. NY. Acad. Sci., 253, 702-710.
11. Norberg, B. (1970) Scand. J. Haematol., 7(6), 445-454.
12. Blank, H.; Taplin, D. and Roth, F.J. (1960) Arch. Dermatol., 81, 667-680.
13. Vanden Bossche, H. (1985) Curr. Top. Med. Mycol., 1, 313-351.
14. De Nollin, S.; Van Belle, H.; Goossens, F.; Thone, F. and Borgers, M. (1977) Antimicrob. Agents Chemother., 11(3), 500-513.
15. Borgers, M.; De Nollin, S.; Thoné, F. and Van Belle, H. (1977) J. Histochem. Cytochem., 25(3), 193-199.
16. Kobayashi, D.; Kondo, K.; Uehara, N.; Otokozawa, S.; Tsuji, N.; Yagihaski, A. and Watanabe, N. (2002) Antimicrob. Agents Chemother., 46(10), 3113-3117.
17. Van Cutsem, J.; Van Gerven, F.; Cauwenbergh, G.; Odds, F., and Janssen, P.A.J. (1991) J. Am. Acad. Dermatol., 25(2 Pt 1), 257-261.
18. Degreef, H.; Van De Kerckhove, M.; Gevers, D.; Van Cutsem, J.; Vanden Bossche, H. and Borgers, M. (1981) Int. J. Dermatol., 20(10), 662-667.
19. Petranyi, G.; Ryder, NS. and Stütz, A. (1984) Science, 224(4654), 1239-1241.
20. Ryder, N.S. and Mieth, H. (1992) Curr. Top. Med. Mycol., 4, 158-188.
21. Jansen, T.; Xhonneux B.; Borgers, M.; Van Gerven, F. and Van Cutsem, J. (1993) Eur. J. Dermatol., 3, 43-9.
22. Cassone, A.; Mason, R.E. and Kerridge, D. (1981) Sabouraudia, 19(2), 97-110.
23. Cauwenbergh, G. (1992) Curr. Top. Med. Mycol., 4, 88-136.
24. Degreef, H. and De Doncker, P. (1993) J. Am. Acad. Dermatol., 31(3 Pt 2), S25-S30.
25. Degreef H. (1996) Cutis, 58(1), 90-93.
26. Degreef H. and De Doncker P. (2000) in Fighting fungal Infections around the globe, (Wells Ed.), Medical Holdings, England, pp. 85-95.
27. Seebacher C. (2004) Hautarzt, 55(2), 150-157.
28. Wahlgren, C.F.; Kaaman, T. and Wikstrom, U. (1993) Läkartidningen, 90(18), 1761-1763.
29. Hällgren, J.; Petrini, B. and Wahlgren, C.F. (2004) Med. Mycol., 42(6), 505-509.
30. Bolognia, J.L.; Jorrizzo, J.L. and Rapini, P.R. (2003) in Dermatology, (Mosby, Ed), Elsevier Limited, London, pp. 2024
31. Rippon, J.W. (1985) Curr. Top. Med. Mycol., 1, 208-234
32. Degreef, H. (1992) Curr. Top. Med. Mycol., 4, 189-206.
33. Degreef, H.; Mariën, K. and De Veylder, H. (1987) Rev. Infect. Dis., 9(1), 104.
34. Leenutaphong, V.; Tangwiwat, S.; Muanprasat, C.; Niumpradit, N. and Sritaveesuwan, R. (1999) J. Med. Assoc. Thai., 82(10), 1006-1010.
35. Degreef H. and De Doncker P. (2000) in Fighting fungal Infections around the globe, (Wells, Ed.), Medical Holdings, England, pp. 56-65.
36. Repka, M.A.; O'Haven, J.; See, C.H.; Gutta, K. and Munjal, M. (2002) Int. J. Pharm., 245(1-2), 25-36.
37. Gupta, A.K. and Scher, R.K. (1998) Lancet, 351(9102), 541-542.
38. Scher, R.K. (1996) J. Am. Acad. Dermatol, 35(3 Pt 2), S2-S5.
39. Debruyne, D. and Coquerel, A. (2001) Clin. Pharmacokinet., 40(6), 441-472.
40. Niewerth, M. and Korting, H.C. (1999) Drugs, 58(2), 283-296.
41. Piraccini, B.M. and Tosti, A. (1999) Drug Saf, 21(3), 187-201.
42. Favre, B.; Ghannoum, M.A. and Ryder, N.S. (2004) Med. Mycol, 42(6), 525-529.
43. Mukherjee, P.K.; Leidich, S.D.; Isham, I.; Leitner, I.; Ryder, N.S. and Ghannoum, M.A. (2003) Antimicrob. Agents Chemother., 47(1), 82-86.
44. Repka, M.A.; Mididoddi, P.K. and Stodghill, S.P. (2004) Int. J. Pharmaceut., 282(1-2), 95-106.
45. Haneke,E. (1991) Semin. Dermatol., 10(1), 41-53.
46. Daniel, C.R. 3rd (1996) J. Am. Acad. Dermatol, 35(3 Pt 2), S21-S25.
47. Baran, R. and Hay, R.J. (1985) Clin. Exp. Dermatol., 10(5), 413-418.
48. Hay, R.J. (1985) Clin. Exp. Dermatol, 10(2), 111-115.
49. Nolting, S. (1984) Dermatologica, 169(Suppl. 1), 117-120.
50. Roberts, D.T.; Hay, R.J.; Doherty, V.R.; Richardson, M.D. and Clayton, Y.M. (1989) Ann. NY. Acad. Sci., 544, 586-587.
51. Hay, R.J.; Clayton, Y.M.; Moore, M.K. and Midgely, G. (1988) Br. J. Dermatol., 119(3), 359-66.
52. Gupta, A.K.; Einarson, T.R.; Summerbell, R.C. and Shear, N.H. (1998) Drugs, 55(5), 645-674.
53. Roberts, D.T. (1997) Dermatology, 194(Suppl. 1) 37-39.
54. Weitzman, I. and Summerbell, R.C. (1995) Clin. Microbiol Res., 8(2), 240-259.
55. Haneke, E.; Tajerbashi, M.; De Doncker, P. and Heremans, A. (1998) Dermatology, 196(3), 323-329.
56. Cauwenbergh, G.; Degreef, H.; Heykants, J.; Woestenborghs, R.; van Rooy, P. and Haeverans, K. (1988) J. Am. Acad. Dermatol., 18(2 Pt 1), 263-269.
57. Willemsen, M.; De Doncker, P.; Willems, J.; Woestenborghs, R.; van de Velde, V.; Heykants, J. and van Cutsem, J. (1992) J. Am. Acad. Dermatol., 26(5 Pt 1), 731-735.
58. Matthieu, L.; De Doncker, P.; Cauwenbergh, G.; Woestenborgh, R.; van de Velde, V.; Janssen, P.A.J. and Dockx, P. (1991) Clin. Exp. Dermatol., 16(5), 374-376.
59. Faergemann, J. (1985) Semin. Dermatol, 4, 173-184.
60. Borgers, M.; Cauwenbergh, G.; Van de Ven, M.A.; Del Palacio-Hernanz, A. and Degreef, H. (1987) Int. J. Dermatol., 26(9), 586-589.
61. Faergemann, J. and Borgers, M. (1990) Acta Derm. Venerol, 70(2), 172-176.
62. Leeming, J.P. and Notman, F.H. (1987) J. Clin. Microbiol., 25(10), 2017-2019.
63. Leeming, J.P.; Sansom, J.E. and Burton, J.L. (1997) Br. J. Dermatol., 137(5), 764-767.
64. Marcon, M.J. and Powell, D.A. (1992) Clin. Microbiol. Rev., 5(2), 101-119.
65. Piérard-Franchimont, C. and Piérard, G.E. (2002) Dermatology, 204(4), 344-347.
66. Hay, R.J. and Graham-Brown, R.A. (1997) Clin. Exp. Dermatol., 22(1), 3-6.
67. Faergemann, J. (2000) Am. J. Clin. Dermatol, 1(2), 75-80.
68. Yoshimura, T.; Kudoh, K.; Aiba, S. and Tagami, H. (1995) J. Dermatol Treat., 6, 113-116.
69. Van Gerven, F. and Odds, F. (1995) Mycoses, 38(9-10), 389-393.
70. Faergemann, J. and Frederikkson, T. (1981) J. Invest. Dermatol., 77(3), 314-318.
71. Bäck, O.; Faergemann, J. and Hörnqvist, R. (1985) J. Am. Acad. Dermatol, 12(1 Pt 1), 56-61.
72. Shuster, S. (1984) Br. J. Dermatol, 111(5), 235-242.
73. Bergbrant, I.M. (1995) Curr. Top. Med. Mycol., 6, 95-112.
74. Ran, Y.; Yoshiike, T. and Ogawa, H. (1993) J. Med. Vet. Mycol., 31(1), 77-85.
75. Ortonne, J.P.; Lacour J.P.; Vitetta, A. and Le Fichoux, Y. (1992) Dermatology, 184(4), 275-280.
76. Faergemann, J. (2002) Clin. Microbiol. Rev., 15(4), 545-563.
77. Ring, J.; Abeck, D., and Neuber, K. (1992) Allergy, 47(4 Pt 1), 265-269.
78. Clemmensen, O.J. and Hijorth, N. (1983) Semin. Dermatol., 2, 26-29.
79. Bäck, O.; Scheynius, A. and Johansson, S.G.O. (1995) Arch. Dermatol. Res., 287(5), 448-451.
80. Broberg, A. and Faergemann, J. (1995) Acta Derm. Venereol., 75(1), 46-49.
81. Nakabayshi, A.; Su, Y. and Guillot, J. (2000) Med. Mycol, 38(5), 337-341.
82. Kieffer, M.; Bergbrant, I.M.; Faergemann, J.; Jemec, GBE.; Ottevanger, V.; Skov, PS. and Svejgaard, E. (1990) J. Am. Acad. Dermatol, 22(5 Pt 1), 739-742.
83. Savolainen, J.; Lammintausta, K.; Kalimo, K. and Viander, M. (1993) Clin. Exp. Allergy, 23(4), 332-339.
84. Ikezawa, Z.; Kondo, M.; Okajima, M.; Nishimura, Y. and Kono, M. (2004) Eur. J. Dermatol., 14(6), 400-406.
85. Svejgaard, E.; Larsen, P.; Deleuran, M.; Ternowitz, T., and Roed-Petersen, N. (2004) Eur. Acad. Dermatol. Venereol., 18(4), 445-449.
86. Nikkels, A.F. and Pierard, G.E. (2003) Dermatology, 206(4), 398-400.
87. Concannon, P.; Gisoldi, E.; Phillips, S. and Grossman, R. (2001) Pediatr. Dermatol., 18(2), 149-155.
88. Balkis, M.M.; Leidich, S.D.; Mukherjee, P.K. and Ghannoum, M.A. (2002) Drugs, 62(7), 1025-1040,
89. Sanglard, D.; Ischer, F.; Monod, M. and Bille, J. (1997) Microbiology, 143(Pt 2), 405-416.
90. Perea, S.; Fothergill, A.W.; Sutton, D.A. and Rinaldi, M.G. (2001) J. Clin. Microbiol., 39(1), 385-388.
91. Gupta, A.K. and Kohli, Y. (2003) Br. J. Dermatol, 149(2), 296-305.
92. Fostel, J.M. and Lartey, P.A. (2000) Drug Discov. Today, 5(1), 25-32.
93. Chandrasekar, P.H. and Manavathu, E. (2001) Drugs Today (Barc.), 37(2), 135-148.
94. Wildfeuer, A.; Seidl, H.P.; Paule, I. and Haberreiter, A. (1998) Mycoses, 41(7-8), 309-319.
95. SCH-56292 (1996) Drugs Future, 21, 160-166.
96. Fung-Tomc, J.C.; Huczko, E.; Minassian, B. and Bonner, D.P. (1998) Antimicrob. Agents Chemother., 42(2), 313-318.
97. Wess, L. and Haan, K. (2004) BioCentury, 12(24), A1-20.
98. Odds, F.; Ausma, J.; Van Gerven, F.; Woestenborghs, F.; Meerpoel, L.; Heeres, J.; Vanden Bossche, H. and Borgers M. (2004) Antimicrob. Agents Chemother., 48(2), 388-391.
99. Vanden Bossche, H.; Ausma, J.; Bohets, H.; Vermuyten, K.; Willemsens, G.; Marichal, P.; Meerpoel, L.; Odds, F. and Borgers, M. (2004) Antimicrob. Agents Chemother., 48(9), 3272-3278.
100. Meerpoel, L.; Backx, L.J.J.; Van der Veken, L.J.E.; Heeres, J.; Corens, D.; De Groot, A.; Odds, F.; Van Gerven, F.; Woestenborghs, F.A.A.; Van Breda, A.; Oris, M.; Van Dorsselaer, P.; Willemsens, G.H.M.; Vermuyten, K.; Marichal, P.J.M.G.; Vanden Bossche, H.; Ausma, J. and Borgers, M. (2005) J. Med. Chem., 48(6), 2184-2193.
101. Hay, R.J. (2004) Ned. Tijdschr. Derm. Venerol., 14, 353-355.
102. Hay, R.J.; Clayton, Y.M.; De Silva, N.; Midgley, G. and Rossor, E. (1996) Br. J. Dermatol, 135(6), 955-8.
103. Timen, A.; Bovee, L.; Leentvaar-Kuijpers, A.; Peerbooms, P.G. and Coutinho, R.A. (1999) Ned. Tijdschr. Geneeskd, 143, 24-7.
104. Tack, D.A.; Fleischer, A. Jr.; McMichael, A. and Feldman, S. (1999) Pediatr. Dermatol., 16(1), 75-9.
105. Allen, H.B.; Honig, P.J.; Leyden, J.J. and McGinley, K.J. (1982) Pediatrics, 69(1), 81-83.
106. Greer, D.L. (2000) Int. J. Dermatol., 39(4), 302-304.